The 2017 Preclinical Form and Formulation for Drug Discovery Gordon Research Conference will present cutting-edge research on evaluation of appropriate form and enabling formulations for drug candidates to facilitate the mechanistic understanding and development of drug delivery from drug discovery.
Capsugel’s David Vodak, Sr. Director, Pharmaceutical R&D, is the session chair for the discussion on Amorphous Pharmaceuticals: New Insights into Predicting Stability and Designing Formulations (Monday, June 5th from 7:30 pm - 9:30 pm).
In addition, Aaron Stewart, Sr. Scientist, R&D, will present a poster titled, Impact of Drug-rich Colloids of Itraconazole and HPMCAS on Membrane Flux In Vitro and Oral Bioavailability in Rats. Join us in Vermont!
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.